Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
Abstract Background Nivolumab and pembrolizumab have not been directly compared in clinical trials, and the aim of this study is to investigate the efficacy and safety of nivolumab versus pembrolizumab in patients with advanced hepatocellular carcinoma (HCC) in real-world practice. Methods We retros...
Gorde:
| Egile Nagusiak: | , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMC
2023-08-01
|
| Saila: | BMC Cancer |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1186/s12885-023-11298-z |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|